
Critical angle reflection imaging for label-free quantification of molecular interactionsAward last edited on: 5/19/2023
Sponsored Program
STTRAwarding Agency
NIH : NIGMSTotal Award Amount
$2,195,647Award Phase
2Solicitation Topic Code
859Principal Investigator
Nguyen LyCompany Information
Biosensing Instrument Inc (AKA: BI)
One West Elliot Road Suite 111
Tempe, AZ 85284
Tempe, AZ 85284
(480) 491-2777 |
info2bi@biosensingusa.com |
www.biosensingusa.com |
Research Institution
Arizona State University
Phase I
Contract Number: 1R42GM143986-01Start Date: 8/15/2021 Completed: 2/14/2022
Phase I year
2021Phase I Amount
$254,738Phase II
Contract Number: 4R42GM143986-02Start Date: 8/15/2021 Completed: 3/31/2024
Phase II year
2022(last award dollars: 2023)
Phase II Amount
$1,940,909Public Health Relevance Statement:
PROJECT NARRATIVE Critical angle reflection imaging (CARi) technology will be developed for label-free quantification of molecular interaction kinetics. This technology is uniquely suitable for in-situ measurement of binding kinetics of membrane proteins on the cell surface with single cell resolution and is compatible with surface plasmon resonance imaging and fluorescence imaging. CARi will have a large impact on biomedical research of cellular processes, discovery of biomarkers, and screening of drug candidates.
Project Terms: